Prosecution Insights
Last updated: May 29, 2026

UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.

54 pending office actions • 40 art units • 53 examiners • 0 of 54 (0%) have an AI response strategy ready • 78 patents granted in the last 365 days

Portfolio Summary

54
Total Pending OAs
28
Non-Final OAs
21
Final Rejections
5
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 53 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

24
Overdue
0
Due this week
18
Due this month
6
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 53 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (24)Due ≤ 30 days (18)Due ≤ 60 days (6)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
38
Medium (70%)
5
Easy (9%)
11
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only35 (65%)
§102 only3 (6%)
§112 only5 (9%)
No statute on record11 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

41
Life Sciences
76% of docket
4
Information Tech
7% of docket
1
Communications
2% of docket
3
Semiconductors
6% of docket
5
Mechanical / Eng
9% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

540 h
Manual time on pending OAs
108 h
Time saved (low, 20%)
189 h
Time saved (mid, 35%)
4.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOPKINS, SAMANTHA LAKE 2 57.9% +61.5%
HANEY, AMANDA MARIE 1 36.6% +44.1%
JOHNSON, EMILY KATHARINE 1 100.0% +0.0%
DAVIS, BRIAN J 1 84.9% -4.4%
ROBINSON, HOPE A 1 67.9% +43.2%
GREENE, JOSEPH L 1 63.2% +36.7%
JOHANAS, JACQUELINE T 1 63.5% +30.1%
ROSENTHAL, ANDREW S 1 51.6% +41.5%
NEAGU, IRINA 1 46.6% +57.9%
GILL, RACHEL B 1 65.6% +27.7%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18840617 Compositions and Methods for Suppression of Flowering in Sugarcane and Energycane JOHNSON, EMILY KATHARINE 39d
18696420 POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES DAVIS, BRIAN J 62d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19012392 METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY HANEY, AMANDA MARIE 163d overdue
18681212 NEUROSURGICAL NAVIGATION SYSTEM REFERENCE ARRAY APPARATUS JOHANAS, JACQUELINE T 72d overdue
17783345 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF HOPKINS, SAMANTHA LAKE 52d overdue
18276916 ANTI-LAIR1 ANTIBODIES FOR THE TREATMENT OF CANCER HOPKINS, SAMANTHA LAKE 17d overdue
18286025 METHODS, KITS, AND APPROACHES FOR VIRAL VACCINES GILL, RACHEL B 8d
18568137 3D-PRINTABLE SHEAR-THINNING POLYSACCHARIDE-BASED NANOCOMPOSITE HYDROGEL FOR BIOMIMETIC TISSUE ENGINEERING ROSENTHAL, ANDREW S 26d
18440187 Multi-Mode Configurable Magnetic Antenna Array for Detecting and Defending Against Malicious Attacks on Semiconductor Integrated Circuits GREENE, JOSEPH L 27d
18560558 QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2 NEAGU, IRINA 63d

Top Art Units

Art UnitApps
1662 3
1671 3
1641 3
1631 3
1682 2
1652 2
1629 2
3783 2
1632 2
1677 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19012392 METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY HANEY, AMANDA MARIE 1682 Other Final Rejection 163d overdue Pending Jan 07, 2025
18840617 Compositions and Methods for Suppression of Flowering in Sugarcane and Energycane JOHNSON, EMILY KATHARINE 1662 §103 Non-Final OA 39d Pending Aug 22, 2024
18696420 POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES DAVIS, BRIAN J 1614 §103 Final Rejection 62d Pending Mar 28, 2024
18598468 IL-1RA CDNAS ROBINSON, HOPE A 1652 §103 Non-Final OA 75d Pending Mar 07, 2024
18440187 Multi-Mode Configurable Magnetic Antenna Array for Detecting and Defending Against Malicious Attacks on Semiconductor Integrated Circuits GREENE, JOSEPH L 2443 §103 Final Rejection 27d Pending Feb 13, 2024
18681212 NEUROSURGICAL NAVIGATION SYSTEM REFERENCE ARRAY APPARATUS JOHANAS, JACQUELINE T 3773 §102 Non-Final OA 72d overdue Pending Feb 05, 2024
18568137 3D-PRINTABLE SHEAR-THINNING POLYSACCHARIDE-BASED NANOCOMPOSITE HYDROGEL FOR BIOMIMETIC TISSUE ENGINEERING ROSENTHAL, ANDREW S 1613 §103 Non-Final OA 26d Pending Dec 07, 2023
18560558 QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2 NEAGU, IRINA 1629 §112 Non-Final OA 63d Pending Nov 13, 2023
18286025 METHODS, KITS, AND APPROACHES FOR VIRAL VACCINES GILL, RACHEL B 1671 Other Non-Final OA 8d Pending Oct 06, 2023
18552486 PREDICTION OF POST-OPERATIVE PAIN USING HOSVD STONE, RACHAEL SOJIN 3681 §103 Non-Final OA 77d overdue Pending Sep 26, 2023
18031505 SELF-ASSEMBLING URICASE FUSION PEPTIDES MOEHLMAN, ANDREW TERRY 1655 §103 Non-Final OA 41d Pending Aug 18, 2023
18276916 ANTI-LAIR1 ANTIBODIES FOR THE TREATMENT OF CANCER HOPKINS, SAMANTHA LAKE 1641 §103 Non-Final OA 17d overdue Pending Aug 11, 2023
18264605 ABERRATION CORRECTED OPTICAL ASSEMBLY LEI, JIE 2872 §102 Final Rejection 28d overdue Pending Aug 08, 2023
18275692 SIGMA RECEPTOR LIGANDS FOR TREATING SARS-COV-2 INFECTION ROMERO, KRISTEN WANG 1624 Other Non-Final OA 13d Pending Aug 03, 2023
18263008 ENHANCING METABOLIC FITNESS OF T CELLS TO TREAT CANCER DUNN, LINDSAY MICHELLE 1644 §103 Non-Final OA 83d Pending Jul 26, 2023
18268280 CREATE HUANGLONGBING TOLERANCE BY SILENCING A CITRUS NEGATIVE IMMUNE REGULATOR DELEO, VICTORIA LYNN 1662 §102 Final Rejection Pending Jun 19, 2023
18267144 METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D KONOPKA, CATHERINE ANNE 1635 §103 Non-Final OA 20d Pending Jun 14, 2023
18257237 DIPHENHYDRAMINE AND LACTOFERRIN FOR PREVENTION AND TREATMENT OF COVID-19 COFFA, SERGIO 1658 Other Non-Final OA 56d Pending Jun 13, 2023
18253010 Modified Insecticidal Proteins MEADOWS, CHRISTINA L 1663 §112 Non-Final OA 35d overdue Pending May 15, 2023
18316064 DISTRIBUTED LEDGER PLATFORM FOR ELECTRONIC VOTING AND/OR POLLING LEE, CLAY C 3699 §103 Non-Final OA 35d overdue Pending May 11, 2023
18305971 DETECTING AUDIO DEEPFAKES THROUGH ACOUSTIC PROSODIC MODELING BECKER, TYLER JUSTIN 2657 §103 Non-Final OA 28d Pending Apr 24, 2023
18032648 METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION TOWNSLEY, SARA ELIZABETH 1629 Other Non-Final OA 15d overdue Pending Apr 19, 2023
18297436 FRAMEWORK FOR SUSTAINABLE RECHARGING OF BATTERY ELECTRIC VEHICLES WITH NEAR-PERPETUAL MOBILITY TSO, EDWARD H 2859 §103 Non-Final OA 15d Pending Apr 07, 2023
18191790 AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS NGUYEN, QUANG 1631 §103 Final Rejection 9d overdue Pending Mar 28, 2023
18124426 Functional Nonlinear Wiener-Based Signal Filtering SHOHATEE, IBRAHIM NAGI 2857 §103 Non-Final OA 4d overdue Pending Mar 21, 2023
18178945 HARDWARE ACCELERATION OF EXPLAINABLE MACHINE LEARNING PHAM, KHANH B 2166 §103 Final Rejection 40d Pending Mar 06, 2023
18023456 CONVERSION OF A BIOLOGICALLY SILENT MIRNA BINDING SMALL MOLECULE TO AN MIRNA DEGRADER ANDERSON, REBECCA L 1626 §112 Final Rejection 34d Pending Feb 27, 2023
18114014 T-DNA Free Gene Editing through Transient Suppressing POLQ in Plants CHATTERJEE, JAYANTA 1662 §103 Non-Final OA 5d overdue Pending Feb 24, 2023
17919052 ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS SHIBUYA, MARK LANCE 1631 Other Non-Final OA 3d overdue Pending Oct 14, 2022
17918887 ENHANCING AAV-MEDIATED DELIVERY AND TRANSDUCTION WITH POLYVINYL ALCOHOL POPA, ILEANA 1633 §103 Final Rejection 30d overdue Pending Oct 13, 2022
18045563 AUTOMATED CYBERATTACK DETECTION USING TIME-SEQUENTIAL DATA, EXPLAINABLE MACHINE LEARNING, AND/OR ENSEMBLE BOOSTING FRAMEWORKS LIN, SHERMAN L 2447 §103 Final Rejection 22d Pending Oct 11, 2022
17918052 SHEATH/CATHETER SECURING DEVICE ALLEN, ROBERT F 3783 §103 Final Rejection 27d Pending Oct 10, 2022
17995050 METHODS TO PREVENT SARS-COV-2 INFECTION AND TREAT COVID-19 BARRERA, IMMACULADA 1671 Other Final Rejection 28d Pending Sep 29, 2022
17906098 MODIFIED ARRESTIN-1 TO ENHANCE PHOTORECEPTOR SURVIVAL IN RETINAL DISEASE KIM, TAEYOON 1631 §103 Final Rejection 5d overdue Pending Sep 12, 2022
17802872 COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF DOING THE SAME HEITMEIER, KENDALL NICOLE 1621 §103 Non-Final OA 24d overdue Pending Aug 26, 2022
17800687 Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors ZOU, NIANXIANG 1671 Other Non-Final OA 19d overdue Pending Aug 18, 2022
17792310 CARBONIC ANHYDRASE II COMPOSITIONS AND METHODS OF USE THEREOF MOAZZAMI, NAGHMEH NINA 1652 §103 Non-Final OA 63d Pending Jul 12, 2022
17788519 IMMUNOTHERAPY FOR DIRECT REPROGRAMMING OF CANCER CELLS INTO IMMUNE CELLS/ANTIGEN PRESENTING CELLS/DENDRITIC CELLS DACE DENITO, ALEXANDRA GERALDINE 1636 §103 Final Rejection 9d Pending Jun 23, 2022
17784733 REVERSIBLE ENDOLUMINAL OCCLUSION DEVICE FOR HEALING OF COLORECTAL ANASTOMOSIS PRICE, NATHAN R 3783 §103 Final Rejection 70d overdue Pending Jun 13, 2022
17783345 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF HOPKINS, SAMANTHA LAKE 1641 Other Final Rejection 52d overdue Pending Jun 08, 2022
17772266 GENE THERAPY VECTORS PENNINGTON, KATIE LEIGH 1634 §103 Non-Final OA 51d overdue Pending Apr 27, 2022
17762543 VACCINE THERAPY FOR RAN PROTEIN DISEASES WANG, CHANG YU 1675 Other Final Rejection 35d Pending Mar 22, 2022
17686624 METHODS OF PERMITTING A SUBJECT TO RECEIVE MULTIPLE DOSES OF RECOMBINANT ADENO-ASSOCIATED VIRUS WEN, SHARON X 1641 §103 Final Rejection 112d overdue Pending Mar 04, 2022
17635631 ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF CHENG, KAREN 1623 §103 Final Rejection 26d Pending Feb 15, 2022
17584505 MACHINE LEARNING DEVELOPMENT USING SUFFICIENTLY-LABELED DATA DIEP, DUY T 2123 §103 Non-Final OA 27d Pending Jan 26, 2022
17622032 FRAGMENT-BASED SCREENING TO IDENTIFY SMALL MOLECULES THAT SELECTIVELY BIND RNA YOUNG, BRIAN ELLIS 1684 §112 Final Rejection 15d Pending Dec 22, 2021
17555320 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS SINGH, ANOOP KUMAR 1632 §112 Non-Final OA 16d Pending Dec 17, 2021
17540121 RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1) MOLOYE, TITILAYO 1632 Other Non-Final OA 21d Pending Dec 01, 2021
17603302 MODIFIED AAV VECTORS THAT DAMPEN THE HUMORAL IMMUNE RESPONSE WANG, RUIXUE 1672 §103 Non-Final OA 31d overdue Pending Oct 12, 2021
17479326 METHODS AND ASSAYS FOR IMMUNE PHENOTYPING KIRWIN, STEFANIE JOHANNA 1677 §103 Non-Final OA 14d Pending Sep 20, 2021
17428475 METHODS FOR CANCER SCREENING AND MONITORING BY CANCER MASTER REGULATORS MARKERS IN LIQUID BIOPSY SISSON, BRADLEY L 1682 §103 Final Rejection 19d Pending Aug 04, 2021
17269041 PROTEIN AND PEPTIDE BIOMARKERS FOR TRAUMATIC INJURY TO THE CENTRAL NERVOUS SYSTEM TRAN, CHAU NGUYEN BICH 1677 §103 Non-Final OA 125d overdue Pending Feb 17, 2021
17053691 MAGNETIC LIPOSOMES AND RELATED TREATMENT AND IMAGING METHODS HARTLEY, MICHAEL G 1618 §103 Non-Final OA 19d overdue Pending Nov 06, 2020
16340738 METHOD AND APPARATUS FOR IMPROVED DETERMINATION OF NODE INFLUENCE IN A NETWORK LIU, GUOZHEN 1686 §103 Non-Final OA 9d overdue Pending Apr 10, 2019

Managing UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month